M&A Deal Summary

Apollo Endosurgery Acquires Apollo Endosurgery

On December 29, 2016, Apollo Endosurgery acquired medical products company Apollo Endosurgery

Acquisition Highlights
  • This is Apollo Endosurgery’s 1st transaction in the Medical Products sector.
  • This is Apollo Endosurgery’s 1st transaction in the United States.
  • This is Apollo Endosurgery’s 1st transaction in Texas.

M&A Deal Summary
Date 2016-12-29
Target Apollo Endosurgery
Sector Medical Products
Buyer(s) Apollo Endosurgery
Deal Type Merger
Advisor(s) Piper Jaffray Companies (Financial)
Cooley (Legal)

Target

Apollo Endosurgery

Austin, Texas, United States
Apollo Endosurgery, Inc. (old) is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 500 million people globally, as well as other gastrointestinal disorders.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Apollo Endosurgery

Austin, Texas, United States
Category Company
Founded 2005
Sector Life Science
Employees202
Revenue 77M USD (2022)
DESCRIPTION

Apollo Endosurgery is a developer of therapeutic antibodies that bind and inhibit bioactive lipids that contribute to disease. The company concluded mid-stage clinical development of drug candidates iSONEP™ (sphingomab) in wet age-related macular degeneration and ASONEP™ (anti-S1P antibody for systemic delivery) in renal cell carcinoma in 2015. Apollo Endosurgery was incorporated in 2005 and is based in Austin, Texas.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Merger) 1 of 1
State (Texas) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
Mergr

Product

Company

Legal